Skip to main content
Erschienen in: Current Neurology and Neuroscience Reports 7/2021

01.07.2021 | Headache (R.B. Halker Singh and J. VanderPluym, Section Editors)

Cluster Headache: A Review and Update in Treatment

verfasst von: Himanshu Suri, Jessica Ailani

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 7/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The treatment of cluster headache has evolved to include a handheld neuromodulation device and a monoclonal antibody in addition to more traditional agents.

Recent Findings

Galcanezumab is an approved treatment for episodic cluster headache. The non-invasive vagal nerve stimulator has been shown to be effective as a treatment for episodic cluster headache. Dedicated pituitary imaging may not be necessary with a normal MRI of the brain.

Summary

Cluster headache is the most common trigeminal-autonomic cephalalgia, characterized by unilateral, frequent, debilitating attacks associated with ipsilateral autonomic symptoms. Attacks have a circadian and, often, seasonal pattern with periods of remission that can last months to years in episodic patients. Though a rare disease, an increasing number of studies have revealed novel targets for treatment. Treatment in cluster headache should focus on early intervention to reduce frequency of attacks and the length of the cycle, which improves outcomes and disability. Acute therapy is used to treat attacks, while bridging and preventive therapies are combined to reduce cycle length.
Case 1: A 43-year-old man presents with the chief complaint of severe headaches. Upon general examination, he seems uncomfortable, agitated, and exhausted. He states that he hasn’t “slept in over a week because of debilitating headaches.” His headaches start around the same time every night: when he lays down to go to sleep. The pain is described as sharp, like a “hot poker” to his left eye. His partner has noticed that his eye droops and turns red when the pain starts. The attacks come on abruptly and prevent him from sleeping. The severe pain lasts 30 to 45 min, but he has mild-to-moderate pain that lingers for the rest of the night.
He has seen his primary care physician, an allergist, and an ear, nose, and throat (ENT) specialist before coming to see a neurologist.
Similar headaches occurred last year during the month of October as well. On further questioning, he reports that these headache attacks have been occurring almost yearly for the past 7 years. Each year, these headaches come on as the weather is changing and occur on a nightly basis for about 3 to 4 weeks.
Literatur
3.••
Zurück zum Zitat Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211 Diagnostic Criteria by IHS Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211 Diagnostic Criteria by IHS
9.••
11.
Zurück zum Zitat Dousset V, Laporte A, Legoff M, Traineau MH, Dartigues JF, Brochet B. Validation of a brief self-administered questionnaire for cluster headache screening in a tertiary center. Headache. 2009;49(1):64–70.CrossRef Dousset V, Laporte A, Legoff M, Traineau MH, Dartigues JF, Brochet B. Validation of a brief self-administered questionnaire for cluster headache screening in a tertiary center. Headache. 2009;49(1):64–70.CrossRef
12.
Zurück zum Zitat Weaver-Agostoni J. Cluster headache. Am Fam Physician. 2013;88(2):122–8.PubMed Weaver-Agostoni J. Cluster headache. Am Fam Physician. 2013;88(2):122–8.PubMed
16.••
Zurück zum Zitat Grangeon L, O'Connor E, Danno D, TMP N, Cheema S, Tronvik E, et al. Is pituitary MRI screening necessary in cluster headache? Cephalalgia. 2021:333102420983303. doi: 10.1177/0333102420983303 New findings regarding work up for CH. Grangeon L, O'Connor E, Danno D, TMP N, Cheema S, Tronvik E, et al. Is pituitary MRI screening necessary in cluster headache? Cephalalgia. 2021:333102420983303. doi: 10.1177/0333102420983303 New findings regarding work up for CH.
22.••
Zurück zum Zitat Pearson SM, et al. Effectiveness of oxygen and other acute treatments for cluster headache: results from the cluster headache questionnaire, an International Survey. Headache. 2019;0:l–15 Population survey to CH therapies. Pearson SM, et al. Effectiveness of oxygen and other acute treatments for cluster headache: results from the cluster headache questionnaire, an International Survey. Headache. 2019;0:l–15 Population survey to CH therapies.
31.
Zurück zum Zitat Negro A, Koverech A, Martelletti P. Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential. J Pain Res. 2018;11:515–26.CrossRef Negro A, Koverech A, Martelletti P. Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential. J Pain Res. 2018;11:515–26.CrossRef
37.••
Zurück zum Zitat Obermann M, Nägel S, Ose C, Sonuc N, Scherag A, Storch P, et al. Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial. Lancet Neurol. 2021;20(1):29–37. https://doi.org/10.1016/S1474-4422(20)30363-XObjective findings of steroid use in CH.CrossRefPubMed Obermann M, Nägel S, Ose C, Sonuc N, Scherag A, Storch P, et al. Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial. Lancet Neurol. 2021;20(1):29–37. https://​doi.​org/​10.​1016/​S1474-4422(20)30363-XObjective findings of steroid use in CH.CrossRefPubMed
40.
Zurück zum Zitat Devoghel JC. Cluster headache and sphenopalatine block. Acta Anaesthesiol Belg. 1981;32(1):101–7.PubMed Devoghel JC. Cluster headache and sphenopalatine block. Acta Anaesthesiol Belg. 1981;32(1):101–7.PubMed
44.
Zurück zum Zitat Burish M. Cluster headache and other trigeminal autonomic cephalalgias. Continuum (Minneap, Minn). 2018;24(4, Headache):1137–56 **Great source for review of CH and other TACs. Burish M. Cluster headache and other trigeminal autonomic cephalalgias. Continuum (Minneap, Minn). 2018;24(4, Headache):1137–56 **Great source for review of CH and other TACs.
53.••
55.••
56.••
Zurück zum Zitat Seijo-Fernandez F, Saiz A, Santamarta E, Nader L, Alvarez-Vega MA, Lozano B, et al. Long-term results of deep brain stimulation of the mamillotegmental fasciculus in chronic cluster headache. Stereotact Funct Neurosurg. 2018;96(4):215–22. https://doi.org/10.1159/000489937another long-term study with DBS as potential treatment for CCH.CrossRefPubMed Seijo-Fernandez F, Saiz A, Santamarta E, Nader L, Alvarez-Vega MA, Lozano B, et al. Long-term results of deep brain stimulation of the mamillotegmental fasciculus in chronic cluster headache. Stereotact Funct Neurosurg. 2018;96(4):215–22. https://​doi.​org/​10.​1159/​000489937another long-term study with DBS as potential treatment for CCH.CrossRefPubMed
57.••
Zurück zum Zitat Nilson N. Mendes Neto, Jessika Thais da Silva Maia, Juliano Jose da Silva, Sergio Adrian Fernandes Dantas, Marcelo Rodrigues Zacarkim, Daniel Duarte Rolim, Erich T Fonoff. The treatment of chronic cluster headache with deep brain stimulation of the posterior hypothalamus. Neurosurgery. 2018 Sept;65(CN_suppl_1):115. Available from: 10.1093/neuros/nyy303.200 Another DBS trial for CCH, unfortunately death noted Nilson N. Mendes Neto, Jessika Thais da Silva Maia, Juliano Jose da Silva, Sergio Adrian Fernandes Dantas, Marcelo Rodrigues Zacarkim, Daniel Duarte Rolim, Erich T Fonoff. The treatment of chronic cluster headache with deep brain stimulation of the posterior hypothalamus. Neurosurgery. 2018 Sept;65(CN_suppl_1):115. Available from: 10.1093/neuros/nyy303.200 Another DBS trial for CCH, unfortunately death noted
59.••
60.
Zurück zum Zitat Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.CrossRef Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.CrossRef
Metadaten
Titel
Cluster Headache: A Review and Update in Treatment
verfasst von
Himanshu Suri
Jessica Ailani
Publikationsdatum
01.07.2021
Verlag
Springer US
Erschienen in
Current Neurology and Neuroscience Reports / Ausgabe 7/2021
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-021-01114-1

Weitere Artikel der Ausgabe 7/2021

Current Neurology and Neuroscience Reports 7/2021 Zur Ausgabe

Sleep (M. Thorpy and M. Billiard, Section Editors)

Sleep Disorders in Mitochondrial Diseases

Neurology of Systemic Diseases (J. Biller, Section Editor)

Effects of the Menstrual Cycle on Neurological Disorders

Headache (R.B. Halker Singh and J. VanderPluym, Section Editors)

Retinal Migraine: Evaluation and Management

Demyelinating Disorders (J. Bernard and M. Cameron, Section Editors)

Economics of Multiple Sclerosis Disease-Modifying Therapies in the USA

Headache (R.B. Halker Singh and J. VanderPluym, Section Editors)

Nutraceuticals and Behavioral Therapy for Headache

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.